GRANITE-001获得FDA快速通道指定用于治疗结直肠癌

2018-12-22 MedSci MedSci原创

Gritstone Oncology是一家临床阶段生物技术公司,致力于开发下一代癌症免疫疗法以对抗多种癌症,近日宣布GRANITE-001已经获得FDA快速通道指定用于治疗结直肠癌。

Gritstone Oncology是一家临床阶段生物技术公司,致力于开发下一代癌症免疫疗法以对抗多种癌症,近日宣布GRANITE-001已经获得FDA快速通道指定用于治疗直肠癌GRANITE-001是一种免疫疗法,含有患者特异性抗原,该抗原由Gritstone专有的EDGETM人工智能平台鉴定,是驱动肿瘤特异性T细胞攻击的最相关的新抗原。GRANITE-001与免疫检查点阻断剂联用疗法正在一项名为GO-004I/II临床研究中进行评估,该研究用于治疗常见的实体瘤,包括转移性非小细胞肺癌、微卫星稳定直肠癌食管癌和膀胱癌。

Gritstone Oncology的联合创始人,总裁兼首席执行官Andrew Allen博士说:结肠直肠癌仍然是导致癌症死亡的主要因素,并且第一代免疫疗法对结肠直肠癌仍然效果不佳。我们相信GRANITE-001有可能通过其高度个性化的设计成为这些患者的有价值的治疗选择。在个体化免疫疗法的开发中,利用肿瘤标志物或新抗原特定于患者自身的肿瘤细胞已经成为了癌症治疗的下一个前沿。美国食品和药物管理局授予快速通道指定,以促进发展并加快对治疗的审查,并有可能治疗严重疾病。接受快速通道指定的治疗剂可以从与该机构的早期和频繁通信中受益,目的是更快地向患者提供的新疗法。


原始出处:

http://www.firstwordpharma.com/node/1613078#axzz5aJrWexZu

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1404363, encodeId=b0c51404363b1, content=<a href='/topic/show?id=b80be308fc' target=_blank style='color:#2F92EE;'>#FDA快速通道指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7308, encryptionId=b80be308fc, topicName=FDA快速通道指定)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er0mAxKX6eKqEe3tZQyIScfFScwvOKb51A1u5oPlkicYKTR2AicBK7U0icJmjBf8t7KibHLllwoTPesbA/132, createdBy=65072466385, createdName=changfy, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449880, encodeId=6b31144988051, content=<a href='/topic/show?id=775e52084ac' target=_blank style='color:#2F92EE;'>#快速通道指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52084, encryptionId=775e52084ac, topicName=快速通道指定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88a5514460, createdName=qidongfanjian, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453206, encodeId=c475145320627, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356166, encodeId=fdb03561668a, content=每一例患者都要设计,时间能不能来得及?将来价格会不会很吓人, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Dec 23 07:54:10 CST 2018, time=2018-12-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1404363, encodeId=b0c51404363b1, content=<a href='/topic/show?id=b80be308fc' target=_blank style='color:#2F92EE;'>#FDA快速通道指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7308, encryptionId=b80be308fc, topicName=FDA快速通道指定)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er0mAxKX6eKqEe3tZQyIScfFScwvOKb51A1u5oPlkicYKTR2AicBK7U0icJmjBf8t7KibHLllwoTPesbA/132, createdBy=65072466385, createdName=changfy, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449880, encodeId=6b31144988051, content=<a href='/topic/show?id=775e52084ac' target=_blank style='color:#2F92EE;'>#快速通道指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52084, encryptionId=775e52084ac, topicName=快速通道指定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88a5514460, createdName=qidongfanjian, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453206, encodeId=c475145320627, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356166, encodeId=fdb03561668a, content=每一例患者都要设计,时间能不能来得及?将来价格会不会很吓人, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Dec 23 07:54:10 CST 2018, time=2018-12-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1404363, encodeId=b0c51404363b1, content=<a href='/topic/show?id=b80be308fc' target=_blank style='color:#2F92EE;'>#FDA快速通道指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7308, encryptionId=b80be308fc, topicName=FDA快速通道指定)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er0mAxKX6eKqEe3tZQyIScfFScwvOKb51A1u5oPlkicYKTR2AicBK7U0icJmjBf8t7KibHLllwoTPesbA/132, createdBy=65072466385, createdName=changfy, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449880, encodeId=6b31144988051, content=<a href='/topic/show?id=775e52084ac' target=_blank style='color:#2F92EE;'>#快速通道指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52084, encryptionId=775e52084ac, topicName=快速通道指定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88a5514460, createdName=qidongfanjian, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453206, encodeId=c475145320627, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356166, encodeId=fdb03561668a, content=每一例患者都要设计,时间能不能来得及?将来价格会不会很吓人, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Dec 23 07:54:10 CST 2018, time=2018-12-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1404363, encodeId=b0c51404363b1, content=<a href='/topic/show?id=b80be308fc' target=_blank style='color:#2F92EE;'>#FDA快速通道指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7308, encryptionId=b80be308fc, topicName=FDA快速通道指定)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er0mAxKX6eKqEe3tZQyIScfFScwvOKb51A1u5oPlkicYKTR2AicBK7U0icJmjBf8t7KibHLllwoTPesbA/132, createdBy=65072466385, createdName=changfy, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1449880, encodeId=6b31144988051, content=<a href='/topic/show?id=775e52084ac' target=_blank style='color:#2F92EE;'>#快速通道指定#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52084, encryptionId=775e52084ac, topicName=快速通道指定)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88a5514460, createdName=qidongfanjian, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453206, encodeId=c475145320627, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Mon Dec 24 08:23:00 CST 2018, time=2018-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=356166, encodeId=fdb03561668a, content=每一例患者都要设计,时间能不能来得及?将来价格会不会很吓人, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Sun Dec 23 07:54:10 CST 2018, time=2018-12-23, status=1, ipAttribution=)]
    2018-12-23 lovetcm

    每一例患者都要设计,时间能不能来得及?将来价格会不会很吓人

    0